Tumor cells disturb the balance of osteoblast and osteoclast activity by secretion of bone-active regulatory factors such as endothelin-1 (ET1), interleukin-6 (IL6) and transforming growth factor β (TGFβ) in order to enhance bone turnover and release of nutrients and growth factors. This evidence concerns the gene EDN1 and neoplasm.